Changes and prognostic impact of inflammatory nutritional factors during neoadjuvant chemoradiotherapy for patients with resectable and borderline resectable pancreatic cancer.
Minoru OshimaKeiichi OkanoHironobu SutoYasuhisa AndoHideki KamadaTsutomu MasakiShigeo TakahashiToru ShibataYasuyuki SuzukiPublished in: BMC gastroenterology (2020)
In addition to pre-NACRT mGPS, ΔCRP/Alb after NACRT could provide prognostic value in the patients with PDAC treated by NACRT.